Supplier News Breaks Archives
Sandoz Inc. has rolled out lansoprazole capsules, amoxicillin capsules and clarithromycin tablets, a generic version of the combination medicine Prevpac from Takeda Pharmaceuticals.
After issuing an alert yesterday, GlaxoSmithKline Consumer Healthcare is voluntarily recalling all alli weight-loss products from U.S. and Puerto Rico retailers.
Dr. Reddy's Laboratories has launched amlodipine besylate and atorvastatin calcium tablets in the U.S. market.
Roscoe Medical and Carex Health Brands plan to merge, creating a leading manufacturer, marketer and distributor of home health care products.
The nutritionals business of Perrigo Co. plc is partnering with KanPak LLC to manufacture store-brand adult nutritional drinks, comparable to Ensure products.
Actavis plc and Valeant Pharmaceuticals International Inc. have received approval from the Food and Drug Administration for Metronidazole 1.3% Vaginal Gel, an antibiotic for the treatment of bacterial vaginosis (BV).
GlaxoSmithKline has issued a warning to consumers that some bottles of its alli over-the-counter weight-loss aid have been subject to tampering.
Ben Fischer, president and chief operating officer at Crossmark, has been named to succeed chief executive officer Joe Crafton, who is retiring after 26 years at the company.
Frito-Lay North America has added new varieties to its Lay's potato chip and Rold Gold pretzel brands.
John LaBonty has been appointed president and chief executive officer at Boldface Group Inc., a celebrity beauty licensing company,
Mario Reis has been hired as executive vice president of supply chain at Coty Inc.
Moberg Pharma AB this week plans to begin shipping a new patent-pending formulation of its Kerasal Nail fungal nail product to U.S. consumers.
The Food and Drug Administration has approved Xolair (omalizumab), a medication jointly developed by Genentech and Novartis for the treatment of chronic idiopathic urticaria (CIU), a form of chronic hives.